Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study.
Bilan YangXiaoli XiHongsheng YuHao JiangZixi LiangAbdukyamu SmayiBin WuYidong YangPublished in: Cancer reports (Hoboken, N.J.) (2024)
This study revealed no significant difference in OS between SR and ablation for early-stage HCC, with SR providing better RFS and ablation demonstrating better safety profiles and lower hospital costs. These findings offer valuable insights for clinicians in determining optimal treatment strategies for early-stage HCC patients, particularly in terms of balancing efficacy, safety, and cost considerations.
Keyphrases
- early stage
- end stage renal disease
- sentinel lymph node
- newly diagnosed
- ejection fraction
- radiofrequency ablation
- chronic kidney disease
- randomized controlled trial
- systematic review
- catheter ablation
- healthcare
- prognostic factors
- palliative care
- peritoneal dialysis
- single cell
- radiation therapy
- adverse drug
- atrial fibrillation
- combination therapy
- patient reported